Comparative modeling and docking studies of p16ink4/Cyclin D1/Rb pathway genes in lung cancer revealed functionally interactive residue of RB1 and its functional partner E2F1
Open Access
- 1 January 2013
- journal article
- research article
- Published by Springer Nature in Theoretical Biology and Medical Modelling
- Vol. 10 (1) , 1
Abstract
Lung cancer is the major cause of mortality worldwide. Major signalling pathways that could play significant role in lung cancer therapy include (1) Growth promoting pathways (Epidermal Growth Factor Receptor/Ras/ PhosphatidylInositol 3-Kinase) (2) Growth inhibitory pathways (p53/Rb/P14ARF, STK11) (3) Apoptotic pathways (Bcl-2/Bax/Fas/FasL). Insilico strategy was implemented to solve the mystery behind selected lung cancer pathway by applying comparative modeling and molecular docking studies.Keywords
This publication has 10 references indexed in Scilit:
- Previous Lung Diseases and Lung Cancer Risk: A Systematic Review and Meta-AnalysisPLOS ONE, 2011
- The STRING database in 2011: functional interaction networks of proteins, globally integrated and scoredNucleic Acids Research, 2010
- A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor geneGenes, Chromosomes and Cancer, 2010
- Lung CancerNew England Journal of Medicine, 2008
- GRAMM-X public web server for protein-protein dockingNucleic Acids Research, 2006
- Promoter Hypermethylation of Multiple Genes in Sputum Precedes Lung Cancer Incidence in a High-Risk CohortCancer Research, 2006
- Focus on lung cancerCancer Cell, 2002
- Passive Smoking and Lung Cancer Risk: What Is the Story Now?JNCI: Journal of the National Cancer Institute, 1998
- The accumulated evidence on lung cancer and environmental tobacco smokeBMJ, 1997
- Errors in protein structuresNature, 1996